LOXL2 serves as a prognostic biomarker associated with immune landscape in lung adenocarcinoma

Asian J Surg. 2024 Nov 15:S1015-9584(24)02547-8. doi: 10.1016/j.asjsur.2024.10.213. Online ahead of print.

Authors

Nan Wei¹, Shenying Yang¹, Xuan Wu¹, Xiaoju Zhang²

Affiliations

¹ Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, 450003, China.
² Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, 450003, China. Electronic address: [email protected].

PMID: 39550267
DOI: 10.1016/j.asjsur.2024.10.213

No abstract available

Publication types

Letter